|
|
|||||||
Multiple Myeloma |
* Department of Haematology, Erasmus University Medical Center, Rotterdam
° Department of Internal Medicine Ikazia Hospital, Rotterdam, the Netherlands
Correspondence: Johannes J.A. Auwerda, MD, Erasmus MC, Dept of Hematology, 3000 CA Rotterdam, PO Box 2040, the Netherlands. Phone: international +31.10.4633740. Fax: internatioal +31.10.4635814. E-mail: jja.auwerda{at}ikazia.nl
Prothrombotic coagulation abnormalities were analyzed in patients with untreated multiple myeloma. Increases in factor VIII, in von Willebrand factor and a decrease in protein S were observed and these changes were strongly associated with disease stage. No difference in baseline coagulation parameters was found between patients with and without subsequent venous thromboembolism.
Key words: newly diagnosed multiple myeloma, coagulation abnormalities, vWF, factor VIII, antiphospholipid antibodies, protein S.
This article has been cited by other articles:
![]() |
D. C. Johnson, S. Corthals, C. Ramos, A. Hoering, K. Cocks, N. J. Dickens, J. Haessler, H. Goldschmidt, J. A. Child, S. E. Bell, et al. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping Blood, December 15, 2008; 112(13): 4924 - 4934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Kristinsson, T. R. Fears, G. Gridley, I. Turesson, U.-H. Mellqvist, M. Bjorkholm, and O. Landgren Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma Blood, November 1, 2008; 112(9): 3582 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Eby Bleeding and Thrombosis Risks in Plasma Cell Dyscrasias Hematology, January 1, 2007; 2007(1): 158 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |